## Revenue and Profitability Trends##

The company, C015, has demonstrated a consistent upward trend in revenue from Q1 2020 to Q2 2025, starting at $19,000,000 and reaching $63,500,000 by Q2 2025. This growth is mirrored in the cost of goods sold (COGS), which also increased over the same period. Consequently, the gross profit has risen from $7,000,000 in Q1 2020 to $31,300,000 in Q2 2025. The gross margin percentage has also shown a steady improvement, starting at 36.8% in Q1 2020 and climbing to 49.3% in Q2 2025, indicating enhanced profitability on its core products.

## Operating Expenses and Income##

Operating expenses (OPEX) have also seen a gradual increase, from $11,000,000 in Q1 2020 to $22,200,000 in Q2 2025. This increase is driven by consistent growth in R&D expenses, selling expenses, and administrative expenses. Despite the rise in OPEX, the company has transitioned from an operating loss of $4,000,000 in Q1 2020 to an operating income of $9,100,000 in Q2 2025. This turnaround signifies a significant improvement in the company's ability to manage its operating costs relative to its revenue growth.

## Net Income and Earnings Per Share##

The company's net income has followed a similar trajectory to operating income, moving from a net loss of $4,450,000 in Q1 2020 to a net profit of $8,260,000 in Q2 2025. Correspondingly, the basic earnings per share (EPS) have improved from -$0.35 in Q1 2020 to $0.59 in Q2 2025, reflecting the positive impact of increased profitability on shareholder value.

## Cash Flow and Liquidity##

Free cash flow has shown a positive trend, growing from -$2,100,000 in Q1 2020 to $2,800,000 in Q2 2025. Cash and equivalents have also steadily increased, starting at $6,800,000 in Q1 2020 and reaching $11,100,000 in Q2 2025. This indicates a healthy improvement in the company's ability to generate cash and manage its liquidity.

## Balance Sheet Highlights##

Total assets have grown consistently from $29,000,000 in Q1 2020 to $45,900,000 in Q2 2025. This growth is primarily attributed to increases in property, plant, and equipment, and accounts receivable. Total liabilities have seen a slight increase from $10,700,000 to $11,600,000 over the same period. As a result, shareholders' equity has increased significantly from $18,300,000 in Q1 2020 to $34,300,000 in Q2 2025, demonstrating strong equity growth. Notably, inventory levels have remained constant at $0 throughout the observed period.
